Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche.

Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche.

The 616 shareholders in attendance, who represented 77.03% of the total Roche Holding, Comcast, Eaton Corp and National Presto Industries are included in this Analyst Blog. Today's Research Daily ...

Wake up with Oxfordshire's latest news, great music and conversation with Sophie.

At close: March 28 at 4:00:00 PM EDT ...